cyclosporine has been researched along with Angiofollicular Lymph Hyperplasia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, Y; Hosoi, H; Kato, T; Murata, S; Nakao, T; Sonoki, T; Tamura, S; Warigaya, K; Yamamoto, S; Yamashita, Y | 1 |
| Azuma, K; Furukawa, T; Iwasaki, T; Kuragano, T; Masumoto, M; Minagawa, Y; Mizusaki, K; Yoshida, M | 1 |
| Aoki, S; Fujimoto, S; Kawabata, H; Kurose, N; Masaki, Y; Nara, K; Nishikori, M; Ohara, S; Sakai, T; Takai, K; Tsukamoto, N; Yamada, S; Yanagisawa, H | 1 |
| Hirano, T; Komuta, K; Kumanogoh, A; Maeda, Y; Manabe, Y; Mizuno, Y; Morita, T; Nakabayashi, A; Nameki, S; Narazaki, M; Nishida, S; Nishide, M; Shibahara, T; Shima, Y; Takamatsu, H; Watanabe, A; Yagita, M; Yamaguchi, Y | 1 |
| Chen, LYC; Fajgenbaum, DC; Skinnider, BF; Wilson, D | 1 |
| Kamei, H; Nishioka, H; Takegawa, H | 1 |
| Morinobu, A; Onishi, A; Saegusa, J; Shirai, T; Waki, D | 1 |
| Eiro, M; Fujiwara, M; Iwasaki, T; Kanno, M; Kazama, JJ; Numata, T; Oda, A; Saito, H; Satoh, M; Tanaka, K; Tanaka, M | 1 |
| Ankou, M; Hagihara, M; Hua, J; Inoue, M; Iwaki, Y; Ota, Y | 1 |
| Hirata, H; Kaneko, H; Konishi, Y; Mitani, S; Mizutani, C; Nishi, K; Sakamaki, T; Takahashi, S; Tsudo, M; Ukyo, N | 1 |
| Ikeda, T; Kato, T; Kunieda, T; Murayama, M; Tokuyama, K; Yamada, R; Yamaga, Y; Yamakita, N | 1 |
| Muryoi, A; Sasaki, T; Satoh, J; Sekiguchi, Y; Takahashi, T; Takasawa, N | 1 |
| Gonda, A; Illes, A; Miltenyi, Z; Remenyik, E; Tar, I; Toth, J | 1 |
| Bertero, MT; Caligaris-Cappio, F; De Maestri, M | 1 |
2 review(s) available for cyclosporine and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Disease Management; Disease Susceptibility; Humans; Immunosuppressive Agents; Patient Outcome Assessment; Platelet Count; Recurrence; Thrombocytopenia | 2020 |
Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Topics: Adolescent; Aged; Bone Marrow; Calcineurin Inhibitors; Cardiomyopathies; Castleman Disease; Cyclosporine; Edema; Female; Fever; Fibrosis; Glucocorticoids; Hepatomegaly; Humans; Interleukin-6; Male; Primary Myelofibrosis; Renal Insufficiency; Splenomegaly; Syndrome; Tacrolimus; Thrombocytopenia; Treatment Outcome | 2018 |
12 other study(ies) available for cyclosporine and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
Topics: Castleman Disease; Cyclosporine; Female; Humans; Intracranial Hemorrhages; Middle Aged; Rituximab | 2021 |
TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
Topics: Biopsy; Castleman Disease; Cyclosporine; Edema; Female; Humans; Kidney Diseases; Middle Aged; Steroids; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A | 2022 |
Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Castleman Disease; Cyclosporine; Female; Humans; Japan; Male; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Survival Rate; Treatment Failure; Treatment Outcome; Young Adult | 2021 |
Adrenalitis and anasarca in idiopathic multicentric Castleman's disease.
Topics: Abdominal Pain; Adrenal Gland Diseases; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Azetidines; Bone Marrow; Bortezomib; Castleman Disease; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Edema; Fever; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Purines; Pyrazoles; Renal Insufficiency; Reticulin; Sulfonamides; Thrombocytopenia | 2021 |
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Castleman Disease; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Risk Factors | 2018 |
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Topics: Abdominal Pain; Anti-Inflammatory Agents; Castleman Disease; Cyclosporine; Female; Fever; Glomerulonephritis, Membranoproliferative; Humans; Immunosuppressive Agents; Kidney; Kidney Glomerulus; Methylprednisolone; Middle Aged; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |
Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Edema; Female; Fever; Humans; Immunosuppressive Agents; Middle Aged | 2013 |
Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Topics: Aged; Antibodies, Monoclonal, Humanized; Castleman Disease; Cyclosporine; Edema; Female; Fever; Humans; Interleukin-2; Platelet Count; Renal Insufficiency; Rituximab; Syndrome; Thrombocytopenia; Treatment Outcome | 2015 |
Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
Topics: Antibodies, Monoclonal, Humanized; Castleman Disease; Cyclosporine; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged | 2016 |
A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged | 2019 |
Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Female; Humans; Immunomodulation; Immunosuppressive Agents; Neoplasm, Residual; Paraneoplastic Syndromes; Pemphigus; Retroperitoneal Neoplasms; Thalidomide | 2009 |
Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma.
Topics: Castleman Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Middle Aged; Sarcoma, Kaposi | 2000 |